Oxford

Main page content

Mixed vaccine schedules offer strong booster responses after two doses of CoronaVac vaccine

1 day 22 hours ago

A third booster dose of either the ChAdOx1 nCoV-19 (Oxford-AstraZeneca), BNT162b2 (Pfizer-BioNTech), AD26.COV2-S (Janssen) or CoronaVac (SinoVac) coronavirus vaccine induce a significant increase in antibody levels in those who have previously received two doses of CoronaVac. The strongest responses were seen with mixed schedules, including against the Delta and Omicron variants of concern.

admn5323@ox.ac.uk

Review highlights risk factors associated with violence in schizophrenia

1 week ago

Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).

admn4008@ox.ac.uk

New research sheds light on how ultrasound could be used to treat psychiatric disorders

2 weeks ago

A new study in macaque monkeys has shed light on which parts of the brain support credit assignment processes (how the brain links outcomes with its decisions) and, for the first time, how low-intensity transcranial ultrasound stimulation (TUS) can modulate both brain activity and behaviours related to these decision-making and learning processes.

admn4008@ox.ac.uk

Undergraduate offers released amid strong competition for places

2 weeks 1 day ago

More than 3600 talented students will today receive offers of places for undergraduate study from October 2022, after a second year of online interviews as a result of the pandemic. This is an increase of 2.6% on the previous year and means that 38% of those interviewed have secured offers.

otss1451@ox.ac.uk
Checked
3 hours 46 minutes ago
Subscribe to Oxford feed